CD274 and neoplasm: 68Ga-NOTA-Nb109 exhibited promising target-to-background ratios in MC38-hPD-L1 tumor and MC38-hPD-L1/KO tumor (11.4±0.29 and 6.33±0.53 tumor-to-muscle ratios in 1h, respectively).